Hainan Shuangcheng Pharmaceut Tangible Net Worth Ratio
Hainan Shuangcheng Pharmaceut tangible net worth ratio. Hainan Shuangcheng Pharmaceut (002693) has a Tangible Net Worth Ratio of 54.7% as of June 2026. This metric is calculated by deducting intangible assets (CN¥194.40 Million) from net assets (CN¥429.45 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Hainan Shuangcheng Pharmaceut (002693) strategic investment index to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Hainan Shuangcheng Pharmaceut (2009–2025)
Tangible net worth ratio of Hainan Shuangcheng Pharmaceut from 2009 to 2025. This chart shows how Hainan Shuangcheng Pharmaceut's Tangible Net Worth Ratio has changed across 17 annual periods from 2009 to 2025. As of June 2026, the ratio stands at 54.7%, reflecting net assets of CN¥429.45 Million with intangible assets of CN¥194.40 Million CNY. See 002693 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Hainan Shuangcheng Pharmaceut Tangible Net Worth Ratio by Year (2009–2025)
Hainan Shuangcheng Pharmaceut tangible net worth ratio by year from 2009 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Hainan Shuangcheng Pharmaceut from 2009 to 2025, covering 17 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Hainan Shuangcheng Pharmaceut (002693) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 55.0% | CN¥420.53 Million | CN¥189.34 Million | CN¥825.78 Million | ▼ -2.5 pp |
| 2024 | 57.5% | CN¥411.61 Million | CN¥175.02 Million | CN¥783.87 Million | ▼ -9.3 pp |
| 2023 | 66.8% | CN¥517.65 Million | CN¥171.78 Million | CN¥803.25 Million | ▼ -4.8 pp |
| 2022 | 71.6% | CN¥580.94 Million | CN¥164.91 Million | CN¥911.02 Million | ▼ -0.7 pp |
| 2021 | 72.3% | CN¥566.75 Million | CN¥156.92 Million | CN¥854.56 Million | ▼ -5.2 pp |
| 2020 | 77.5% | CN¥598.31 Million | CN¥134.38 Million | CN¥907.68 Million | ▼ -5.5 pp |
| 2019 | 83.0% | CN¥678.26 Million | CN¥115.22 Million | CN¥950.98 Million | ▼ -2.6 pp |
| 2018 | 85.6% | CN¥669.69 Million | CN¥96.48 Million | CN¥1.12 Billion | ▼ -1.1 pp |
| 2017 | 86.7% | CN¥761.71 Million | CN¥101.15 Million | CN¥1.38 Billion | ▲ +5.9 pp |
| 2016 | 80.9% | CN¥553.13 Million | CN¥105.85 Million | CN¥1.17 Billion | ▼ -4.7 pp |
| 2015 | 85.5% | CN¥927.61 Million | CN¥134.20 Million | CN¥1.55 Billion | ▼ -9.1 pp |
| 2014 | 94.6% | CN¥893.55 Million | CN¥48.17 Million | CN¥943.54 Million | ▼ -1.5 pp |
| 2013 | 96.1% | CN¥870.62 Million | CN¥33.54 Million | CN¥917.04 Million | ▲ +0.1 pp |
| 2012 | 96.1% | CN¥845.85 Million | CN¥33.26 Million | CN¥886.65 Million | ▲ +4.0 pp |
| 2011 | 92.0% | CN¥228.23 Million | CN¥18.22 Million | CN¥248.06 Million | ▲ +2.4 pp |
| 2010 | 89.6% | CN¥157.82 Million | CN¥16.42 Million | CN¥252.73 Million | ▲ +5.1 pp |
| 2009 | 84.5% | CN¥77.95 Million | CN¥12.06 Million | CN¥97.85 Million | — |